Show simple item record

dc.contributor.authorMerika, EE
dc.contributor.authorGore, M
dc.contributor.authorFearfield, LA
dc.date.accessioned2017-07-05T11:20:01Z
dc.date.issued2017-06
dc.identifier.citationEuropean journal of dermatology : EJD, 2017, 27 (3), pp. 321 - 322
dc.identifier.issn1167-1122
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/688
dc.identifier.eissn1952-4013
dc.identifier.doi10.1684/ejd.2017.2997
dc.formatPrint
dc.format.extent321 - 322
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectHumans
dc.subjectOvarian Neoplasms
dc.subjectErythema
dc.subjectHand Dermatoses
dc.subjectEdema
dc.subjectPolyethylene Glycols
dc.subjectCarboplatin
dc.subjectDoxorubicin
dc.subjectAnticoagulants
dc.subjectAntineoplastic Agents
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectVenous Thromboembolism
dc.titleCaelyx-induced unilateral erythrodysesthaesia secondary to venous thromboembolism.
dc.typeJournal Article
rioxxterms.versionofrecord10.1684/ejd.2017.2997
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2017-06
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEuropean journal of dermatology : EJD
pubs.issue3
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume27
pubs.embargo.termsNo embargo
dc.contributor.icrauthorGore, Martin
dc.contributor.icrauthorMarsden,


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record